Supplemental Financial Information - Income Statement Accounts (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Currency Transaction Gains (Losses) [Line Items] | |||
Currency transaction losses, net | $ (27,094) | $ (18,436) | $ (9,476) |
Design and development | 195,451 | 189,372 | 189,494 |
Identifiable intangible asset amortization | 37,602 | 38,039 | 38,925 |
Bad debt expense, net | 18,279 | 1,202 | 9,149 |
Operating income | |||
Currency Transaction Gains (Losses) [Line Items] | |||
Currency transaction losses, net | (15,544) | (10,212) | (8,780) |
Other non-operating expense, net | |||
Currency Transaction Gains (Losses) [Line Items] | |||
Currency transaction losses, net | $ (11,550) | $ (8,224) | $ (696) |
X | ||||||||||
- Definition Currency Transaction Gains (Losses) [Line Items] No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|